Údarás na Gaeltachta welcomes the announcement by Taoiseach Enda Kenny, today (Wednesday, April 18th) that Mylan, the largest generics pharmaceutical manufacturer in Ireland and one of the world’s leading pharmaceutical companies, is to expand its manufacturing and R&D facility – Bioniche Pharma in Indreabhán, Co. Galway and create up to 220 new jobs.
Bioniche Pharma, an Údarás na Gaeltachta supported company, develops and manufactures sterile injectable pharmaceutical drugs and currently employs approximately 160 people at the Údarás na Gaeltachta Industrial Estate in Inverin in the Galway Gaeltacht. The planned expansion of Mylan’s operations in Ireland, including sites in Dublin, involves R&D and manufacturing capabilities within the company’s respiratory, injectables and oral solids franchises.
Making the announcement Taoiseach Enda Kenny said, ‘Mylan’s decision to expand in both Dublin and Galway is most welcome news. Mylan is a key member of the Irish pharmaceutical sector and one of the top suppliers in the country, providing the market with high quality generic pharmaceuticals and over-the-counter medicines. Today’s announcement, in addition to the company’s proven, 25-year track record as a top employer and reliable exporter in Ireland, demonstrates Mylan’s continued commitment to its Irish operations and recognition for the capabilities of its talented workforce.
Commenting on the announcement, Minister of State at the Department of Arts, Heritage and the Gaeltacht, Dinny Mc Ginley TD said that this investment by Mylan will have substantial economic impact on the Galway Gaeltacht. “Mylan’s decision to significantly expand its facility in Connemara and establish it as a centre of excellence for the company’s injectable pharmaceutical products and R&D processes is a vote of confidence in the area and the local workforce. I commend both IDA Ireland and Údarás na Gaeltachta for attracting this investment to the Galway Gaeltacht. This is a prime example of how Ireland’s enterprise development agencies collaborate to ensure that the West of Ireland and specifically the Gaeltacht areas benefit from job creation through foreign direct investment.”
Mylan currently employ around 700 people in its facilities in Dublin and Galway.
Mylan CEO Heather Bresch said: ‘‘This investment in Mylan’s Irish operations and the growth of our capabilities in the country demonstrate our continued commitment to and confidence in our respiratory franchise and injectables platform, both of which are among Mylan’s many long-term growth drivers. Ireland also has proven to be a valuable location for Mylan, providing the company with access to a skilled and highly educated workforce that shares our strong work ethic and commitment to excellence. I would like to thank Taoiseach Enda Kenny, Minister Richard Bruton, along with IDA Ireland, for all of their support. Importantly, I’d also like to recognize Mylan’s employees in Ireland for their hard work and dedication to our continued success.’’
Welcoming the announcement, Barry O’Leary, CEO of IDA Ireland said, “The expansion of Mylan’s operations at Bioniche, Connemara and in Baldoyle, Dublin are all extremely positive developments for Ireland’s Life Sciences Sector. I wish Mylan every success with this operation and on behalf of IDA Ireland look forward to continuing to work closely with the company in the future.’’